NA
SRPT icon

NewEdge Advisors’s Sarepta Therapeutics SRPT Stock Holding History

NewEdge Advisors’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-200
Closed -$4.35K – 4377
2026
Q1 		$4.35K Hold
200
– – ﹤0.01% 3631
2025
Q4 		$4.3K Sell
200
-4
-2% -$84 ﹤0.01% 3721
2025
Q3 		$3.93K Hold
204
– – ﹤0.01% 3604
2025
Q2 		$3.49K Hold
204
– – ﹤0.01% 3494
2025
Q1 		$13K Hold
204
– – ﹤0.01% 3002
2024
Q4 		$24.8K Sell
204
-8,726
-98% -$1.07M ﹤0.01% 2750
2024
Q3 		$1.12M Buy
8,930
+3,339
+60% +$462K 0.01% 1050
2024
Q2 		$883K Sell
5,591
-1,363
-20% -$175K 0.01% 1130
2024
Q1 		$900K Buy
6,954
+6,582
+1,769% +$806K 0.01% 1048
2023
Q4 		$35.9K Buy
372
+45
+14% +$4.32K ﹤0.01% 2335
2023
Q3 		$39.6K Hold
327
– – ﹤0.01% 2160
2023
Q2 		$37.4K Sell
327
-8
-2% -$1.03K ﹤0.01% 2178
2023
Q1 		$46.2K Sell
335
-11
-3% -$1.43K ﹤0.01% 2037
2022
Q4 		$45 Buy
+346
New +$40.1K ﹤0.01% 3489
2021
Q1 		– Sell
-1,250
Closed -$213K – 1107
2020
Q4 		$213K Buy
+1,250
New +$185K 0.01% 879
2020
Q3 		– Sell
-1,542
Closed -$247K – 974
2020
Q2 		$247K Buy
+1,542
New +$210K 0.01% 723
2018
Q4 		– Sell
-1,369
Closed -$221K – 705
2018
Q3 		$221K Buy
+1,369
New +$187K 0.02% 587

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

NewEdge Advisors's SRPT Position: Q2 2026 in Review

NewEdge Advisors sold out of Sarepta Therapeutics (SRPT) in Q2 2026, closing a stake of 200 shares — an estimated $4.35K sold.

NewEdge Advisors first reported a position in SRPT in Q3 2018 and held it in 17 quarters. The position peaked at $1.12M in Q3 2024. 324 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • NewEdge Advisors reported no remaining Sarepta Therapeutics position as of Q2 2026 after selling out during the quarter.
  • NewEdge Advisors sold 200 Sarepta Therapeutics shares in Q2 2026, an estimated $4.35K.
  • NewEdge Advisors first reported a position in Sarepta Therapeutics in Q3 2018 and held it in 17 quarters.
  • NewEdge Advisors's Sarepta Therapeutics position peaked at $1.12M in Q3 2024.
  • 324 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.